Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Postoperative Antibiotics Following Primary and Secondary Breast Augmentation: A Double-Blinded, Randomized Trial

NCT04834310 is registered in ClinicalTrials.gov with University of California, Los Angeles as lead sponsor.

NCT NCT04834310
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04834310 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Postoperative Antibiotics Following Primary and Secondary Breast Augmentation: A Double-Blinded, Randomized Trial
Lead sponsor
University of California, Los Angeles
Phase
Phase 4
Overall status
Withdrawn
Start date
April 1, 2021
Completion date
July 30, 2024
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

antibiotic resistant infection, antibiotic side effect, capsular contracture associated with breast implant, surgical site infection